Methylphenidate challenge test in adults with attention deficit/hyperactivity disorder (ADHD): Clinical effects and their predictors.,Human Psychopharmacology: Clinical and Experimental

当前位置： X-MOL 学术 › Human Psychopharmacology: Clinical and Experimental › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Methylphenidate challenge test in adults with attention deficit/hyperactivity disorder (ADHD): Clinical effects and their predictors.
Human Psychopharmacology: Clinical and Experimental ( IF 1.672 ) Pub Date : 2020-08-12 , DOI: 10.1002/hup.2740
Daria Piacentino _{1,

2} , Pietro De Rossi _{2,

3} , Georgios D Kotzalidis ₂ , Ignazio Maniscalco ₁ , Maurizio Pompili ₂ , Giancarlo Giupponi ₁ , Christoph Hiemke ₄ , Andreas Conca ₁

Affiliation

Adult and children attention deficit/hyperactivity disorder (ADHD) share similar symptoms and responses to drugs such as methylphenidate (MPH). Yet, in Europe, these drugs remain unlicensed for adults. We aimed to assess the effects of an acute MPH challenge on the four dimensions concentration, impulsivity, tension, and general well‐being in ADHD adults, and identify predictors of improvement.

中文翻译：

成人注意力缺陷/多动障碍 (ADHD) 的哌甲酯激发试验：临床效果及其预测因素。

成人和儿童注意力缺陷/多动障碍 (ADHD) 具有相似的症状和对哌甲酯 (MPH) 等药物的反应。然而，在欧洲，这些药物仍未获得成人许可。我们旨在评估急性 MPH 挑战对 ADHD 成人四个维度的注意力、冲动、紧张和总体幸福感的影响，并确定改善的预测因素。

更新日期：2020-09-18

点击分享查看原文

点击收藏

公开下载